Dr. Alexandre Barros. PhD Tisue Engineering, Regenerative Medicine and Stem Cells in May 2017, University of Minho, Portugal, in collaboration with the Department of Bioengineering, University of California, Berkeley, United States of America; MSc in Technology and Properties of Polymers (2013), at the University of Minho, Portugal and BSc in Biotecnology (2010) at the Polytechnic institute of Viana do Castelo, Portugal. The research developed during the Ph.D. and post-doctoral period originate a spin-off company calls HydrUStent, that are pursuing the clinical trials now. Since April of 2018, Alexandre Barros is IP & Innovation Manager at I3Bs, 3B's Research Group, University of Minho, Portugal with an IP portfolio with more than 120 international patents.
Dr. Alexandre Barros. PhD Tisue Engineering, Regenerative Medicine and Stem Cells in May 2017, University of Minho, Portugal, in collaboration with the Department of Bioengineering, University of California, Berkeley, United States of America; MSc in Technology and Properties of Polymers (2013), at the University of Minho, Portugal and BSc in Biotecnology (2010) at the Polytechnic institute of Viana do Castelo, Portugal. The research developed during the Ph.D. and post-doctoral period originate a spin-off company calls HydrUStent, that are pursuing the clinical trials now. Since April of 2018, Alexandre Barros is IP & Innovation Manager at I3Bs, 3B's Research Group, University of Minho, Portugal with an IP portfolio with more than 120 international patents.